JP2006516532A - 乳癌の新補助的処置 - Google Patents

乳癌の新補助的処置 Download PDF

Info

Publication number
JP2006516532A
JP2006516532A JP2004533117A JP2004533117A JP2006516532A JP 2006516532 A JP2006516532 A JP 2006516532A JP 2004533117 A JP2004533117 A JP 2004533117A JP 2004533117 A JP2004533117 A JP 2004533117A JP 2006516532 A JP2006516532 A JP 2006516532A
Authority
JP
Japan
Prior art keywords
chemotherapeutic agent
administered
patient
administration
diphenyl compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004533117A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006516532A5 (https=
Inventor
ローン、 ジェイ． ブランデス、
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manitoba
Original Assignee
University of Manitoba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Manitoba filed Critical University of Manitoba
Publication of JP2006516532A publication Critical patent/JP2006516532A/ja
Publication of JP2006516532A5 publication Critical patent/JP2006516532A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2004533117A 2002-09-03 2003-09-02 乳癌の新補助的処置 Pending JP2006516532A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40724202P 2002-09-03 2002-09-03
PCT/CA2003/001335 WO2004022163A1 (en) 2002-09-03 2003-09-02 Neoadjuvant treatment of breast cancer

Publications (2)

Publication Number Publication Date
JP2006516532A true JP2006516532A (ja) 2006-07-06
JP2006516532A5 JP2006516532A5 (https=) 2006-08-17

Family

ID=31978443

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004533117A Pending JP2006516532A (ja) 2002-09-03 2003-09-02 乳癌の新補助的処置

Country Status (9)

Country Link
US (2) US20060160755A1 (https=)
EP (1) EP1545709B1 (https=)
JP (1) JP2006516532A (https=)
KR (1) KR20060039387A (https=)
AT (1) ATE378089T1 (https=)
AU (1) AU2003269621A1 (https=)
CA (1) CA2497246A1 (https=)
DE (1) DE60317537T8 (https=)
WO (1) WO2004022163A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201121924D0 (en) * 2011-12-20 2012-02-01 Fahy Gurteen Labs Ltd Detection of breast cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798339A (en) * 1990-12-17 1998-08-25 University Of Manitoba Treatment method for cancer
US5618846A (en) * 1990-12-17 1997-04-08 University Of Manitoba Treatment method for cancer
US5616846A (en) * 1994-10-27 1997-04-01 Kwasnik; Joseph W. Method and apparatus for current regulation and temperature compensation
PL369792A1 (en) * 2001-11-01 2005-05-02 Ym Biosciences, Inc. Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy
US20050119263A1 (en) * 2001-11-09 2005-06-02 Vincent Mark D. Treatment of breast cancer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JPN6009060625, ＬＥＢＷＯＨＬ，Ｄ．Ｅ． ｅｔ ａｌ， Ｎｅｗ ｄｅｖｅｌｏｐｍｅｎｔｓ ｉｎ ｃｈｅｍｏｔｈｅｒａｐｙ ｏｆ ａｄｖａｎｃｅｄ ｂｒｅａｓｔ ｃａｎｃｅｒ， Ａｎｎ Ｏｎｃｏｌ， １９９９， Ｖｏｌ *
JPN6009060629, ＢＥＬＬＩＮＯ，Ｒ． ｅｔ ａｌ， Ｅｐｉｄｏｘｏｒｕｂｉｃｉｎ ａｎｄ ｐａｃｌｉｔａｘｅｌ ａｓ ｐｒｉｍａｒｙ ｃｈｅｍｏｔｈｅｒａｐｙ ｆｏｒ Ｔ ＞ ３ ｃｍ ａｎｄ Ｔ４ ｂｒｅａｓｔ ｃ *
JPN6009060631, ＤＥ，Ｍ．Ａ． ｅｔ ａｌ， Ｄｏｃｅｔａｘｅｌ ｐｌｕｓ ｅｐｉｄｏｘｏｒｕｂｉｃｉｎ ａｓ ｎｅｏａｄｊｕｖａｎｔ ｔｒｅａｔｍｅｎｔ ｉｎ ｐａｔｉｅｎｔｓ ｗｉｔｈ ｌａｒｇｅ ｏｐｅｒａｂｌ *
JPN6009060634, ＴＯＮＧ，Ｆ． ｅｔ ａｌ， 局所進行乳癌に対するＰｒｉｍａｒｙ Ｃｈｅｍｏｔｈｅｒａｐｙ（Ｎｅｏ−ａｄｊｕｖａｎｔ Ｃｈｅｍｏｔｈｅｒａｐｙ）としてのＥｐｉｒｕｂｉｃｉｎ *

Also Published As

Publication number Publication date
DE60317537T8 (de) 2009-02-05
DE60317537T2 (de) 2008-10-23
CA2497246A1 (en) 2004-03-18
EP1545709B1 (en) 2007-11-14
EP1545709A1 (en) 2005-06-29
US20080318880A1 (en) 2008-12-25
KR20060039387A (ko) 2006-05-08
ATE378089T1 (de) 2007-11-15
WO2004022163A1 (en) 2004-03-18
US20060160755A1 (en) 2006-07-20
DE60317537D1 (de) 2007-12-27
AU2003269621A1 (en) 2004-03-29

Similar Documents

Publication Publication Date Title
AU2003244646B2 (en) Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
JP2001247459A (ja) 癌の組み合わせ療法
JP2007511498A (ja) Ｅｔ−７４３とドキソルビシンとを使用することを含むガンの併用療法
JP2007511509A (ja) Ｅｔ−７４３およびパクリタキセルの使用を含むガンの併用療法
JP2000505796A (ja) エダトレキセートおよびタキサン誘導体（例えばパクリタキセル）を用いる癌を処置するための組み合わせ治療方法
JP2006516532A (ja) 乳癌の新補助的処置
CA2179377C (en) Method of treatment of hormone-unresponsive metastatic prostate cancer
JP2006516533A (ja) アントラサイクリンおよびタキサンによる転移性乳癌の治療
JP2005512996A (ja) 乳癌の治療
JP2005512996A5 (https=)
JP2007523825A (ja) 乳癌治療のためのｄｐｐｅと他の化学療法剤との併用
AR063459A1 (es) Metodo para administrar un inhibidor de aurora en el tratamiento del cancer
WO2004022044A1 (en) Use of a combination of a taxane with dppe for the treatment of cancer
JP2006516532A5 (https=)
JP2006516533A5 (https=)
AU2002340668A1 (en) Treatment of breast cancer
KR20110104932A (ko) Ａｖｅ８０６２ 및 도세탁셀이 조합된 항종양 조합물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20060301

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060622

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060622

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091125

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100225

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100304

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100908